Yuri E. Shilov
Research Subjects
Yuri E. Shilov has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Natalia S. Karpova
Mental Health Research Center
5 shared publications - Oleg S. Brusov
Mental Health Research Center
5 shared publications - Tatiana P. Klyushnik
Medline LLC
3 shared publications - A. N. Pozdnyakova
FSBSI “Mental Health Research Centre
2 shared publications - E. A. Kovalenko
Federal Center for Brain and Neurotechnologies
2 shared publications - Elena G. Cheremnykh
Federal State Budgetary Scientific Institution “Russian Mental Health Research Center”, Moscow 115522, Russia
2 shared publications
Latest Publications
- Open Access
- 27 October 2026
- Published by Springer Nature in BMC Psychiatry
Hemostasis profiling in women with paranoid schizophrenia before and after antipsychotic treatment using the Fibrinodynamics method
- 27 October 2026
- Published by Springer Nature in BMC Psychiatry
Open AccessHemostasis profiling in women with paranoid schizophrenia before and after antipsychotic treatment using the Fibrinodynamics method
- Open Access
- 26 June 2025
- Published by Federal Medical Biological Agency in Extreme Medicine
- Vol. 27 (2) , 169-175
Role of fibrinolytic system changes in the development of post-stroke cognitive impairments
Роль изменений системы фибринолиза в развитии постинсультных когнитивных нарушений
- 26 June 2025
- Published by Federal Medical Biological Agency in Extreme Medicine
- Vol. 27 (2) , 169-175
Open AccessRole of fibrinolytic system changes in the development of post-stroke cognitive impairments
Роль изменений системы фибринолиза в развитии постинсультных когнитивных нарушений
- Open Access
- 11 April 2024
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 23 (1) , 85-93
Multifactorial, biomarker-based model for assessing the state of patients with schizophrenia
Relevance. Objective comparison of biological markers and real clinical presentation is especially difficult in mental disorders, which are classified according to a large number of diagnostic criteria and a wide variety of symptoms. Therefore, the development of an effective system of biochemical markers and assessment of their relationship to optimize the diagnosis and treatment of schizophrenia are relevant.The aim of the study was to develop a statistical model that combines known and tested biochemical markers for mental illnesses in patients with schizophrenia.Materials and methods. The study included 47 women aged 18–50 years (median age – 22 years) with the diagnosis of schizophrenia (ICD-10, F20) and 25 healthy women of the same age. The model was based on the functional activity of complement, thrombodynamics parameters, markers of inflammation, glutamate and energy metabolism, and antioxidant defense, which were shown to be associated with the severity of schizophrenia. The listed markers were evaluated in plasma, platelets, and erythrocytes of sick and healthy individuals.Results. Statistical software found pair correlations and features of the distribution of all markers as random variables in the examined groups and evaluated correlations between pairs of markers. Ten biomarkers were identified and united into a system that was adequately described by the logistic regression model. The model was evaluated using the Pearson’s test (χ2(11) = 57.6, p = 0.001) and calculation of correct predictions (91 and 80%) for samples of patients and healthy people, respectively.Conclusion. Calculating the logistic equation resulted in the probability that the patient has schizophrenia involving the immune system, hemostasis, and oxidative stress. This model can be considered as a new formalized approach to the preclinical diagnosis of mental illnesses.
- 11 April 2024
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 23 (1) , 85-93
Open AccessMultifactorial, biomarker-based model for assessing the state of patients with schizophrenia
Relevance. Objective comparison of biological markers and real clinical presentation is especially difficult in mental disorders, which are classified according to a large number of diagnostic criteria and a wide variety of symptoms. Therefore, the development of an effective system of biochemical markers and assessment of their relationship to optimize the diagnosis and treatment of schizophrenia are relevant.The aim of the study was to develop a statistical model that combines known and tested biochemical markers for mental illnesses in patients with schizophrenia.Materials and methods. The study included 47 women aged 18–50 years (median age – 22 years) with the diagnosis of schizophrenia (ICD-10, F20) and 25 healthy women of the same age. The model was based on the functional activity of complement, thrombodynamics parameters, markers of inflammation, glutamate and energy metabolism, and antioxidant defense, which were shown to be associated with the severity of schizophrenia. The listed markers were evaluated in plasma, platelets, and erythrocytes of sick and healthy individuals.Results. Statistical software found pair correlations and features of the distribution of all markers as random variables in the examined groups and evaluated correlations between pairs of markers. Ten biomarkers were identified and united into a system that was adequately described by the logistic regression model. The model was evaluated using the Pearson’s test (χ2(11) = 57.6, p = 0.001) and calculation of correct predictions (91 and 80%) for samples of patients and healthy people, respectively.Conclusion. Calculating the logistic equation resulted in the probability that the patient has schizophrenia involving the immune system, hemostasis, and oxidative stress. This model can be considered as a new formalized approach to the preclinical diagnosis of mental illnesses.
- 21 March 2024
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 124 (3) , 23-29
The relationship between the development of post-stroke cognitive impairment and changes in the coagulation component of hemostasis
OBJECTIVE To evaluate the relationship between the severity of post-stroke cognitive impairment (PSCI) and coagulation parameters assessed using the dynamic thrombophotometry. MATERIAL AND METHODS Thirty-five patients with hemispheric ischemic stroke (IS) with moderate neurological deficit at admission were included. All patients underwent a comprehensive clinical and instrumental assessment according to the current guidelines. On days 10—14, the cognitive status of patients was assessed using the Montreal Cognitive Assessment (MoCA). Coagulation parameters were assessed using the dynamic thrombophotometry at admission, on 6—8th days and 13—15th days from the onset of the disease. A database of laboratory studies of 30 apparently healthy volunteers was used as a comparison group. RESULTS Data analysis revealed that a number of spatial and temporal parameters were within the reference values, and there were no significant changes over time. Nevertheless, though the optical density of the fibrin clot (D) was within the reference values, it showed a steady increase from the admission by the end of the 1st week of the disease (p=0.007) and by 13—15th days (p=0.009). Correlation and multivariate linear regression, including baseline stroke symptom severity, showed significant associations (pth and 13—15th days is a potential prognostic biomarker for the early development of PSCI.
- 21 March 2024
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 124 (3) , 23-29
The relationship between the development of post-stroke cognitive impairment and changes in the coagulation component of hemostasis
OBJECTIVE To evaluate the relationship between the severity of post-stroke cognitive impairment (PSCI) and coagulation parameters assessed using the dynamic thrombophotometry. MATERIAL AND METHODS Thirty-five patients with hemispheric ischemic stroke (IS) with moderate neurological deficit at admission were included. All patients underwent a comprehensive clinical and instrumental assessment according to the current guidelines. On days 10—14, the cognitive status of patients was assessed using the Montreal Cognitive Assessment (MoCA). Coagulation parameters were assessed using the dynamic thrombophotometry at admission, on 6—8th days and 13—15th days from the onset of the disease. A database of laboratory studies of 30 apparently healthy volunteers was used as a comparison group. RESULTS Data analysis revealed that a number of spatial and temporal parameters were within the reference values, and there were no significant changes over time. Nevertheless, though the optical density of the fibrin clot (D) was within the reference values, it showed a steady increase from the admission by the end of the 1st week of the disease (p=0.007) and by 13—15th days (p=0.009). Correlation and multivariate linear regression, including baseline stroke symptom severity, showed significant associations (pth and 13—15th days is a potential prognostic biomarker for the early development of PSCI.
- 1 January 2022
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 122 (12) , 138-142
Cinnabarinic acid as a potential prognostic marker of schizophrenia
ЦЕЛЬ ИССЛЕДОВАНИЯ Разработка метода определения циннабариновой кислоты (CA) и ее непосредственного предшественника 3-гидроксиантраниловой кислоты (3HAA) в плазме крови и исследование их концентраций у больных шизофренией до и после лечения. МАТЕРИАЛ И МЕТОДЫ Исследование проводили на выборке из 23 пациентов женского пола с приступообразно-прогредиентным типом течения шизофрении (F20.01). Уровень CA и 3HAA в плазме крови измеряли с помощью метода тандемной хромато-масс-спектрометрии. РЕЗУЛЬТАТЫ Обнаружена обратная статистически значимая корреляция суммы концентраций CA и 3HAA до лечения с суммарным баллом по шкале PANSS после лечения (R=–0,50; p<0,05). Также обнаружена обратная корреляция концентрации CA до лечения с суммарным баллом по шкале PANSS после лечения (R=–0,41, p=0,052), статистически значимая на уровне тренда (0,05<p<0,1). Таким образом, впервые были определены концентрации CA в крови человека. ЗАКЛЮЧЕНИЕ Полученные связи с клиническими данными показывают потенциальную прогностическую значимость определения уровней CA и 3HAA в плазме крови и повышают актуальность дальнейших исследований.
- 1 January 2022
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 122 (12) , 138-142
Cinnabarinic acid as a potential prognostic marker of schizophrenia
ЦЕЛЬ ИССЛЕДОВАНИЯ Разработка метода определения циннабариновой кислоты (CA) и ее непосредственного предшественника 3-гидроксиантраниловой кислоты (3HAA) в плазме крови и исследование их концентраций у больных шизофренией до и после лечения. МАТЕРИАЛ И МЕТОДЫ Исследование проводили на выборке из 23 пациентов женского пола с приступообразно-прогредиентным типом течения шизофрении (F20.01). Уровень CA и 3HAA в плазме крови измеряли с помощью метода тандемной хромато-масс-спектрометрии. РЕЗУЛЬТАТЫ Обнаружена обратная статистически значимая корреляция суммы концентраций CA и 3HAA до лечения с суммарным баллом по шкале PANSS после лечения (R=–0,50; p<0,05). Также обнаружена обратная корреляция концентрации CA до лечения с суммарным баллом по шкале PANSS после лечения (R=–0,41, p=0,052), статистически значимая на уровне тренда (0,05<p<0,1). Таким образом, впервые были определены концентрации CA в крови человека. ЗАКЛЮЧЕНИЕ Полученные связи с клиническими данными показывают потенциальную прогностическую значимость определения уровней CA и 3HAA в плазме крови и повышают актуальность дальнейших исследований.
- 1 January 2022
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 122 (9) , 68-73
Paired and partial correlations of immune parameters of neuro-immuno-test and coagulation parameters of thrombodynamics test in children with children’s autism
To reveal paired and partial correlations of values of neuro-immuno-test and thrombodynamics test in children with childhood autism and schizophrenia in childhood in a state of exacerbation. The study used a database of children with childhood autism, obtained by us in 2028-2019. The study included 46 patients with childhood autism (CA) aged 2 to 13 years: median age [Q1; Q3] - 5 years [4; 7], 10 girls (22%) and 36 boys (78%)). The thrombodynamics test (TD) was performed on a T-2 thrombodynamics analyzer according to the manufacturer's instructions. It was shown that there is a statistically significant positive correlation (R=0.369, p=0.018) between the acquired immunity parameter: the level of serum antibodies to myelin basic protein (BMP): abBMP parameter, and the main parameter of platelet hemostasis - the time of appearance of spontaneous clots (Tsp). It can be assumed that autoantibodies to BMP block the procoagulant effect of myelin basic protein and thus have an anticoagulant effect. However, this analysis did not take into account the possible effects of other parameter of the neuro-immuno-test and thrombodynamics test. Therefore, when studying the correlation of specific parameters of the neuro-immuno-test and thrombodynamics, it is necessary to take into account the possible modifying effect of other parameters of these tests. It was shown that after subtracting the influence on the main correlation (abBMP & Tsp) of individual thrombodynamic parameters (Vi, V and D), as well as their total influence, the partial correlations become statistically insignificant. This indicates that these TD parameters can, individually or in total, determine the revealed correlation between the levels of antibodies to the basic myelin protein (Basic Myelin Protein) and the time of the appearance of spontaneous clots. Thus, it was shown that the correlations between the studied parameters of the neuro-immuno-test and the indicators of the thrombodynamics test mutually depend on the other indicators of these tests. This confirms the hypothesis that the immune system and the hemostatic system are two different sides of a single supersystem.
- 1 January 2022
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 122 (9) , 68-73
Paired and partial correlations of immune parameters of neuro-immuno-test and coagulation parameters of thrombodynamics test in children with children’s autism
To reveal paired and partial correlations of values of neuro-immuno-test and thrombodynamics test in children with childhood autism and schizophrenia in childhood in a state of exacerbation. The study used a database of children with childhood autism, obtained by us in 2028-2019. The study included 46 patients with childhood autism (CA) aged 2 to 13 years: median age [Q1; Q3] - 5 years [4; 7], 10 girls (22%) and 36 boys (78%)). The thrombodynamics test (TD) was performed on a T-2 thrombodynamics analyzer according to the manufacturer's instructions. It was shown that there is a statistically significant positive correlation (R=0.369, p=0.018) between the acquired immunity parameter: the level of serum antibodies to myelin basic protein (BMP): abBMP parameter, and the main parameter of platelet hemostasis - the time of appearance of spontaneous clots (Tsp). It can be assumed that autoantibodies to BMP block the procoagulant effect of myelin basic protein and thus have an anticoagulant effect. However, this analysis did not take into account the possible effects of other parameter of the neuro-immuno-test and thrombodynamics test. Therefore, when studying the correlation of specific parameters of the neuro-immuno-test and thrombodynamics, it is necessary to take into account the possible modifying effect of other parameters of these tests. It was shown that after subtracting the influence on the main correlation (abBMP & Tsp) of individual thrombodynamic parameters (Vi, V and D), as well as their total influence, the partial correlations become statistically insignificant. This indicates that these TD parameters can, individually or in total, determine the revealed correlation between the levels of antibodies to the basic myelin protein (Basic Myelin Protein) and the time of the appearance of spontaneous clots. Thus, it was shown that the correlations between the studied parameters of the neuro-immuno-test and the indicators of the thrombodynamics test mutually depend on the other indicators of these tests. This confirms the hypothesis that the immune system and the hemostatic system are two different sides of a single supersystem.
- Open Access
- 17 December 2021
- Published by Medical Informational Agency Publishers in Psychiatry (Moscow) (Psikhiatriya)
- Vol. 19 (4) , 76-89
The Role of the Complement System in the Pathogenesis of SARS-CoV-2 Viral Infection in Mental Illness
Introduction: the complement system can be a critical factor in the outcome of SARS-CoV-2 viral infection. Many mental illnesses are characterized by systemic sterile inflammation, in which the complement system is an obligatory participant. Purpose: to present an analysis of scientific data on the role of the complement system in the pathogenesis of viral diseases and the characteristics of the course of COVID-19 in mental patients. Material and methods: the keywords “complement system” “SARS-CoV-2”, “inhibition of the complement system”, “COVID-19” “mental illness” were used to search scientific articles in the databases MEDLINE, PubMed and other bibliographic sources. Conclusion: patients with mental illness are at risk due to physiological and mental characteristics, and infection with SARS-CoV-2 can provoke a relapse of the underlying disease. Therapeutic inhibition of complement system will help reduce this risk and reduce the likelihood of severe complications from systemic inflammation caused by this infection.
- 17 December 2021
- Published by Medical Informational Agency Publishers in Psychiatry (Moscow) (Psikhiatriya)
- Vol. 19 (4) , 76-89
Open AccessThe Role of the Complement System in the Pathogenesis of SARS-CoV-2 Viral Infection in Mental Illness
Introduction: the complement system can be a critical factor in the outcome of SARS-CoV-2 viral infection. Many mental illnesses are characterized by systemic sterile inflammation, in which the complement system is an obligatory participant. Purpose: to present an analysis of scientific data on the role of the complement system in the pathogenesis of viral diseases and the characteristics of the course of COVID-19 in mental patients. Material and methods: the keywords “complement system” “SARS-CoV-2”, “inhibition of the complement system”, “COVID-19” “mental illness” were used to search scientific articles in the databases MEDLINE, PubMed and other bibliographic sources. Conclusion: patients with mental illness are at risk due to physiological and mental characteristics, and infection with SARS-CoV-2 can provoke a relapse of the underlying disease. Therapeutic inhibition of complement system will help reduce this risk and reduce the likelihood of severe complications from systemic inflammation caused by this infection.